BioSpace News Archive

Completes Enrollment of Phase 2 Candida Trial Treats First Patients in Phase 2 Trials in Aspergillus and Candida auris Infections

Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, today announced that it will hold a call for investors and the NPC community on Wednesday, May 20, 2020 at 4:30 pm EDT. “We look forward to speaking to the patient and investor communities about the data from our comp

Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, today announced it has successfully achieved Type 1 Service Organization Control (SOC 2 ® ) compliance examination for its flagship digital health platforms. The audit was performed by Control Logics, who have “i mplemented risk management methodologies and performed security assessments a

Medallia, Inc. (NYSE: MDLA), the global leader in experience management, today announced it has partnered with Veeva Systems, the leader in cloud-based software for the global life sciences industry. Medallia joined the Veeva Technology Partner Program to deliver a tightly integrated solution with Veeva CRM Suggestions that wi

The Froedtert & MCW health network has shown positive results by sending SilverCloud Health, the world’s leading digital mental health platform for healthcare systems and providers, to patients from their care team through Xealth, a leader in enabling digital health at scale.

While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care.

Today, 10x Genomics (Nasdaq: TXG) and One Medical (Nasdaq: ONEM) announced the two organizations are partnering to pioneer a path toward the safe return to work by deploying a comprehensive approach to COVID-19 testing, digital employee symptom screening, and seamless access to remote and in-person care. 10x Genomics is the first of One Medical’s more than 7,000 employer customers to begin executing a multi-pronged,

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will host a key opinion leader (KOL) call to discuss the unmet medical needs in suicide and depression on Tuesday, May 26, 2020 at 1:00 p.m. Eastern Time. The call will feature a discussion with Distinguished University Health Professor Emeritus at

Unprecedented Insight into How Efficiently Their Bodies Burn Calories Allows Users to Take Greater Control Over Their Health and Wellness, in the Comfort of Their Home [19-May-2020] NEW YORK , May 19, 2020 /PRNewswire/ -- Lumen, a health technology company at the forefront of personal health, today announced the global launch of its ground-breaking wellness device:

Oncology Analytics, a leading data analytics and technology-enabled services company dedicated to helping health plans, providers, and patients with solutions that are purpose-built for oncology, today announced that Andrew Norden, MD, MPH, MBA has joined the company as its Chief Medical Officer.